Gold Bennett Cera & Sidener LLP Announces Class Action Lawsuit Against VISX Inc.

    SAN FRANCISCO, March 3 /PRNewswire/ -- Gold Bennett Cera & Sidener LLP
 announced today that it had filed a class action in the United States District
 Court for the Northern District of California on behalf of purchasers of
 VISX, Inc. ("VISX") (Nasdaq:   VISX) common stock during the period between
 March 1, 1999 and February 22, 2000 (the "Class Period"), Case Number
 C-00-20240-PVT.   Plaintiffs seek to recover damages on behalf of all
 purchasers of VISX common stock during the Class Period (the "Class").
     The plaintiffs are represented by the San Francisco law firm of Gold
 Bennett Cera & Sidener LLP.  For over 30 years, Gold Bennett Cera & Sidener
 LLP and its predecessors have successfully engaged in complex commercial
 litigation, including shareholder, consumer and antitrust class actions, in
 federal and state courts throughout the United States, recovering hundreds of
 millions of dollars for its clients.
     The complaint charges VISX and certain of its officers and directors
 (Mark B. Logan, Elizabeth Davila, James W. McCollum, David M. Patino,
 Timothy R. Maier and Kina Lamblin) with violations of the Securities Exchange
 Act of 1934. The complaint alleges that defendants' false and misleading
 statements artificially inflated the price of VISX stock to a Class Period
 high of $103-7/8 from just $30-1/4 per share (split adjusted) at the outset of
 the Class Period. This upsurge in VISX's stock enabled VISX insiders to sell
 1.4 million shares of their VISX stock for $97 million in proceeds.
     Specifically, the Complaint alleges that defendants issued false and
 misleading statements about the steady and increasing revenues the installed
 base of VISX's Excimer Laser systems would provide VISX, the strong procedure
 and equipment royalties VISX was earning, the limited impact of competition
 which would lead to consistent revenue growth and allow VISX to maintain its
 $250 per procedure licensing fee in the United States, and VISX's continued
 market share domination which would result in 2000 EPS of $1.70-1.80.
     On December 10, 1999, VISX received an adverse ruling from the
 International Trade Commission that competitor Nidek had not infringed on
 VISX's patents, and its stock retreated to the $58-$60 range. This cast doubt
 on VISX's competitive position and the ability to maintain its prices.
 However, VISX continued to represent that the $250 per procedure fee was in
 tact. Then, on January 19, 2000, VISX revealed a drop in 4thQ99 revenues
 versus the 3rdQ99 and exposed the problems VISX was having growing its
 business. On these disclosures, VISX's stock fell by 29% in one day to
 $32-1/4. However, it was not until February 22, 2000, that VISX admitted it
 would reduce its per procedure fee to $100. This announcement caused its stock
 price to drop to as low as $16 on huge volume on February 23, 2000.
     If you are a member of the Class described above, you may, no later than
 April 25, 2000, move the Court to serve as lead plaintiff of the Class, if you
 so choose.  In order to serve as lead plaintiff, however, you must meet
 certain legal requirements.  If you wish to discuss this action or have any
 questions concerning this case or your rights or interests, please contact
 Joseph M. Barton, Esq. of Gold Bennett Cera & Sidener LLP, 595 Market Street,
 Suite 2300, San Francisco, California 94105, by telephone at 800-778-1822 or
 415-777-2230, by facsimile at 415-777-5189 or by e-mail at

SOURCE Gold Bennett Cera & Sidener LLP

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.


PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.